Open an account

Definitive Healthcare

DH · NASDAQ

$1.13+$0.03 (+2.73%)TodayMarket closed ·
Prev close $1.10

About DH

Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. The company is headquartered in Framingham, Massachusetts and currently employs 686 full-time employees. The company went IPO on 2021-09-15. The Company’s solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. The company transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. Its business is conducted through AIDH TopCo, LLC (Definitive OpCo).

Employees
686
Headquarters
Framingham, Massachusetts
Listed
Sep 15, 2021
Sector
Health Care
Industry
Health Care Technology
Website
ir.definitivehc.com

DH key statistics

Market cap
159.32M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
674.37K
Volume
393.92K
Open price
$1.11
High today
$1.16
Low today
$1.09
52 Week high
$3.05
52 Week low
$0.6103

Definitive Healthcare (DH) at a glance

As of Oct 20, 2026, Definitive Healthcare (DH) shares are priced at $1.13, giving the company a market cap of 159.32M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.09 and $1.16. The current price is 3.7% above the day's low and 2.6% below its high.

Volume so far is 393.92K shares, below the average of 674.37K shares a day.

Over the past year Definitive Healthcare has ranged from $0.6103 to $3.05, and now sits 21% of the way up that range.

Definitive Healthcare met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.05 per share against an estimate of $0.044.

The average analyst price target is $1.73, 53.5% above the current price, from 5 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

0%of 5 analyst ratings say Buy
  • Buy0.0%
  • Hold60.0%
  • Sell40.0%
Price target · 9 analystsAvg $1.73
Low
$0.707
Now
$1.13
High
$3.15

DH earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 40.8% on average.

  1. Q3 FY24: reported $0.10 per share against an estimate of $0.0821
  2. Q4 FY24: reported $0.08 per share against an estimate of $0.073
  3. Q1 FY25: reported $0.05 per share against an estimate of $0.0248
  4. Q2 FY25: reported $0.07 per share against an estimate of $0.0513
  5. Q3 FY25: reported $0.07 per share against an estimate of $0.0567
  6. Q4 FY25: reported $0.06 per share against an estimate of $0.0627
  7. Q1 FY26: reported $0.06 per share against an estimate of $0.0335
  8. Q2 FY26: reported $0.05 per share against an estimate of $0.044

DH news

  • 12 Health Care Stocks Moving In Monday's After-Market Session

  • Press releasePRNewswire

    Restaurant365 Names Kate Hastings Chief Customer Officer as It Expands Investment in Customer Success

  • Earnings Scheduled For November 6, 2025

  • Avi Kapoor

    Crude Oil Gains Over 1%; EchoStar Posts Q1 Loss

  • Avi Kapoor

    Insulet Posts Upbeat Earnings, Joins Trade Desk, TransMedics Group, Tesla And Other Big Stocks Moving Higher On Friday

  • Avi Kapoor

    US Stocks Higher; Lyft Posts Upbeat Earnings

  • Earnings Scheduled For May 8, 2025

  • What 4 Analyst Ratings Have To Say About Definitive Healthcare

Similar companies

Companies in the same industry as Definitive Healthcare

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.